by Team Small News | May 17, 2025 | Lupin, Pharma
Lupin’s CEO Vinita Gupta and Managing Director Nilesh Gupta recently addressed investors, discussing the company’s strategic plans and the impact of US policies on the pharmaceutical industry. As a major market for Lupin, the US is a significant focus area... by Team Small News | May 9, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth... by Team Small News | Apr 24, 2025 | Lupin, Pharma
Lupin Ltd, a leading pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for its generic version of Tolvaptan tablets. The tablets are indicated for the treatment of autosomal dominant polycystic kidney disease (ADPKD), a... by Team Small News | Apr 11, 2025 | Lupin, Pharma
The BRESER study, conducted by Lupin, has successfully demonstrated the real-world efficacy and safety of their ranibizumab biosimilar, Ranieyes. The study was conducted in collaboration with various medical institutions and evaluated the use of Ranieyes in a diverse... by Team Small News | Apr 8, 2025 | Lupin, Pharma
Lupin Digital Health, a subsidiary of pharmaceutical company Lupin, is expanding its digital therapeutics platform to focus on cardiac care. The platform, known as Lyfe, uses real-time monitoring to track patients’ vitals, activity, and clinical goals, as well... by Team Small News | Apr 4, 2025 | Lupin, Pharma
Lupin Healthcare (UK) Limited, a subsidiary of global pharmaceutical company Lupin Limited, has acquired Renascience Pharma Limited, a UK-based pharmaceutical company specializing in four key specialty products. The acquisition strengthens Lupin’s position in...